Combined GM-CSF/docetaxel beneficial against HR prostate cancer
Publication
, Journal Article
George, DJ; Moul, JW
Published in: Oncology Report
March 1, 2005
Duke Scholars
Published In
Oncology Report
ISSN
1548-5323
Publication Date
March 1, 2005
Issue
SPRING
Start / End Page
51 / 52
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
George, D. J., & Moul, J. W. (2005). Combined GM-CSF/docetaxel beneficial against HR prostate cancer. Oncology Report, (SPRING), 51–52.
George, D. J., and J. W. Moul. “Combined GM-CSF/docetaxel beneficial against HR prostate cancer.” Oncology Report, no. SPRING (March 1, 2005): 51–52.
George DJ, Moul JW. Combined GM-CSF/docetaxel beneficial against HR prostate cancer. Oncology Report. 2005 Mar 1;(SPRING):51–2.
George, D. J., and J. W. Moul. “Combined GM-CSF/docetaxel beneficial against HR prostate cancer.” Oncology Report, no. SPRING, Mar. 2005, pp. 51–52.
George DJ, Moul JW. Combined GM-CSF/docetaxel beneficial against HR prostate cancer. Oncology Report. 2005 Mar 1;(SPRING):51–52.
Published In
Oncology Report
ISSN
1548-5323
Publication Date
March 1, 2005
Issue
SPRING
Start / End Page
51 / 52
Related Subject Headings
- Oncology & Carcinogenesis